The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ...

Two Phase 3 studies have demonstrated that patients can safely switch between adalimumab, a well-known biologic therapy, and ...

ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, ...

Does your hair's length affect how you take care of, maintain, and stop scalp psoriasis from returning? Let's talk about it.

UCB, a global biopharmaceutical company, today announced the presentation of new four-year data in patients with moderate-to-severe plaque psoriasis treated with BIMZELX® (bimekizumab-bkzx), an ...

In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader wondering about COVID-19-induced insulin resistance.

Biocon Biologics presents dermatology data at EADV 2024 Congress, showcasing interchangeability and biosimilarity of ...

Access to adequate care for psoriasis is inconsistent across Europe and the condition remains misunderstood and undertreated.

A new study utilised data from the UK Biobank to shed light on a potential causal link between psoriasis and lung and breast ...

Armstrong, MD, MPH, chief of dermatology, UCLA, discusses clinical trial findings from the phase 2b study on zasocitinib.

Flakes won’t go away? You might be dealing with scalp psoriasis instead of dandruff! Here's how to know the difference ...

Struggling with persistent dandruff can lead to scalp psoriasis. Know the key signs and symptoms to help identify this common ...